These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 24741636)
1. γδ T cell and other immune cells crosstalk in cellular immunity. He Y; Wu K; Hu Y; Sheng L; Tie R; Wang B; Huang H J Immunol Res; 2014; 2014():960252. PubMed ID: 24741636 [TBL] [Abstract][Full Text] [Related]
2. Anti-tumour immunotherapy with Vγ9Vδ2 T lymphocytes: from the bench to the bedside. Braza MS; Klein B Br J Haematol; 2013 Jan; 160(2):123-32. PubMed ID: 23061882 [TBL] [Abstract][Full Text] [Related]
3. Gamma delta T cells and dendritic cells: close partners and biological adjuvants for new therapies. Martino A; Poccia F Curr Mol Med; 2007 Nov; 7(7):658-73. PubMed ID: 18045144 [TBL] [Abstract][Full Text] [Related]
4. Close encounters of different kinds: dendritic cells and gamma delta T cells heighten therapeutic applications. Martino A; Poccia F Immunol Lett; 2005 Oct; 101(1):115. PubMed ID: 15941592 [No Abstract] [Full Text] [Related]
5. Antigen recognition and immunomodulation by gamma delta T cells in bovine tuberculosis. Rhodes SG; Hewinson RG; Vordermeier HM J Immunol; 2001 May; 166(9):5604-10. PubMed ID: 11313400 [TBL] [Abstract][Full Text] [Related]
6. Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells. Schnurr M; Scholz C; Rothenfusser S; Galambos P; Dauer M; Röbe J; Endres S; Eigler A Cancer Res; 2002 Apr; 62(8):2347-52. PubMed ID: 11956095 [TBL] [Abstract][Full Text] [Related]
7. Dendritic cell maturation by innate lymphocytes: coordinated stimulation of innate and adaptive immunity. Münz C; Steinman RM; Fujii S J Exp Med; 2005 Jul; 202(2):203-7. PubMed ID: 16027234 [TBL] [Abstract][Full Text] [Related]
8. Bridging innate and adaptive immunity through gammadelta T-dendritic cell crosstalk. Scotet E; Nedellec S; Devilder MC; Allain S; Bonneville M Front Biosci; 2008 May; 13():6872-85. PubMed ID: 18508701 [TBL] [Abstract][Full Text] [Related]
9. Adoptively transferred ex vivo expanded gammadelta-T cells mediate in vivo antitumor activity in preclinical mouse models of breast cancer. Beck BH; Kim HG; Kim H; Samuel S; Liu Z; Shrestha R; Haines H; Zinn K; Lopez RD Breast Cancer Res Treat; 2010 Jul; 122(1):135-44. PubMed ID: 19763820 [TBL] [Abstract][Full Text] [Related]
10. Involvement of CD56brightCD11c+ cells in IL-18-mediated expansion of human γδ T cells. Tsuda J; Li W; Yamanishi H; Yamamoto H; Okuda A; Kubo S; Ma Z; Terada N; Tanaka Y; Okamura H J Immunol; 2011 Feb; 186(4):2003-12. PubMed ID: 21239711 [TBL] [Abstract][Full Text] [Related]
11. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Gomes AQ; Martins DS; Silva-Santos B Cancer Res; 2010 Dec; 70(24):10024-7. PubMed ID: 21159627 [TBL] [Abstract][Full Text] [Related]
12. gammadelta T cells in cancer immunotherapy: current status and future prospects. Chiplunkar S; Dhar S; Wesch D; Kabelitz D Immunotherapy; 2009 Jul; 1(4):663-78. PubMed ID: 20635991 [TBL] [Abstract][Full Text] [Related]
13. Basic science for the clinician 35: CD1, invariant NKT (iNKT) Cells, and gammadelta T-cells. Sigal LH J Clin Rheumatol; 2005 Dec; 11(6):336-9. PubMed ID: 16371809 [TBL] [Abstract][Full Text] [Related]
14. The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting. Li Y; Li G; Zhang J; Wu X; Chen X Front Immunol; 2020; 11():619954. PubMed ID: 33664732 [TBL] [Abstract][Full Text] [Related]
15. Dendritic cell cross talk with innate and innate-like effector cells in antitumor immunity: implications for DC vaccination. van Beek JJ; Wimmers F; Hato SV; de Vries IJ; Sköld AE Crit Rev Immunol; 2014; 34(6):517-36. PubMed ID: 25597314 [TBL] [Abstract][Full Text] [Related]
16. Integrated immune responses to infection - cross-talk between human gammadelta T cells and dendritic cells. Eberl M; Jomaa H; Hayday AC Immunology; 2004 Jul; 112(3):364-8. PubMed ID: 15196203 [No Abstract] [Full Text] [Related]
17. γδ T cells as a potential tool in colon cancer immunotherapy. Ramutton T; Buccheri S; Dieli F; Todaro M; Stassi G; Meraviglia S Immunotherapy; 2014; 6(9):989-99. PubMed ID: 25341120 [TBL] [Abstract][Full Text] [Related]
18. Regulatory and effector functions of gamma-delta (γδ) T cells and their therapeutic potential in adoptive cellular therapy for cancer. Paul S; Lal G Int J Cancer; 2016 Sep; 139(5):976-85. PubMed ID: 27012367 [TBL] [Abstract][Full Text] [Related]
19. The use of BRM-activated killer cells in adoptive immunotherapy: a pilot study with nine advanced cancer patients. Ebina T; Fujimiya Y; Yamaguchi T; Ogama N; Sasaki H; Isono N; Suzuki Y; Katakura R; Tanaka K; Nagata K; Takano S; Tamura K; Uno K; Kishida T Biotherapy; 1998; 11(4):241-53. PubMed ID: 9950100 [TBL] [Abstract][Full Text] [Related]
20. The interaction of gamma delta T cells with activated macrophages is a property of the V gamma 1 subset. Dalton JE; Pearson J; Scott P; Carding SR J Immunol; 2003 Dec; 171(12):6488-94. PubMed ID: 14662848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]